These outcomes, along with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 support the principle of targeting ACKR3 as a novel solution to modulate the opioid system, which could open up new therapeutic avenues for opioid-linked Issues. Conolidine claims to get a https://stevent902ost3.anchor-blog.com/profile